Adamax: Reference Overview and Reconstitution Notes

Adamax

What it is

Adamax is a synthetic peptide built on the Semax backbone, an analog of the ACTH(4-7) fragment often described as N-acetyl Semax with an adamantane modification. It belongs to the small-peptide, melanocortin-related family and is supplied as a lyophilized research material.

Research context and categorization

Adamax is generally grouped under the cognitive and neuromodulatory (nootropic) research category. It is a structural modification of Semax, and the added N-terminal acetyl group and C-terminal adamantyl group are described as attempts to slow enzymatic breakdown and improve stability relative to unmodified Semax.

In neutral research terms, Adamax is commonly discussed in relation to melanocortin-4 receptor (MC4R) signaling and to downstream pathways such as brain-derived neurotrophic factor (BDNF) expression, the same pathways studied for its parent compound Semax. It is investigated in preclinical and in-vitro contexts for topics including neuroprotection-associated signaling, neuroplasticity-linked pathways, and attention and motivation-related circuitry. These uses are investigational only. They have not been confirmed or approved, and any effects described in the literature are the subject of ongoing study rather than established outcomes in humans.

Status

  • Regulatory status: Research-only, not FDA-approved. The parent compound Semax is approved in Russia and some neighboring countries as a nootropic and neuroprotective agent, but Adamax itself is not approved for human therapeutic use in the United States.
  • Sport status: Not specifically listed by name on the WADA Prohibited List. Note that its parent peptide Semax is derived from a fragment of the hormone ACTH and acts on melanocortin and growth-factor-related pathways, so this peptide class is sometimes discussed in relation to the S2 category (peptide hormones, growth factors, related substances and mimetics), which carries a catch-all clause for substances with a similar structure or biological effect. Anyone subject to testing should treat it as a potential risk and verify current WADA guidance.

Reconstitution notes (general)

For a lyophilized powder, working concentration is calculated as the milligrams of peptide in the vial divided by the millilitres of bacteriostatic water added. For example, a 10 mg vial reconstituted with 2 mL of bacteriostatic water gives a concentration of 5 mg/mL. To work out a specific mixture, see the calculator at our reconstitution and blend calculators.

Dilution and handling notes (compound-specific)

Adamax is supplied as a lyophilized powder and is intended to be reconstituted with bacteriostatic water before laboratory use. Reported working ranges are broad, commonly on the order of 1 mg/mL up to roughly 3 to 5 mg/mL depending on how much water is added to a 10 mg vial. Lower concentrations use more water and are easier to measure in small increments, while higher concentrations use less water.

As a short peptide, Adamax generally goes into solution readily and does not require heat. The practical quirks are mechanical rather than chemical. Add the bacteriostatic water slowly, letting it run down the inner wall of the vial rather than driving it straight onto the powder, then swirl gently and let the vial sit until fully dissolved. Avoid vigorous shaking, which introduces foam and mechanical stress. The solution should end up clear and colorless. If it stays cloudy, shows particulates, or will not fully clear, that is a sign not to use it. One route-specific note appears often in the reference material: for intranasal research preparations, sterile isotonic saline (0.9% sodium chloride) is sometimes used in place of bacteriostatic water, because the benzyl alcohol preservative is harsher on nasal tissue.

Handling and storage

Store the reconstituted solution refrigerated at 2 to 8 C and keep it out of direct light. Wipe the vial stopper with an alcohol swab before drawing, and label the vial with the mix date so the age of the solution is always known. A refrigerated reconstituted peptide is generally treated as usable for about four weeks. Discard the solution if it becomes cloudy or discolored, or if floaters or particulates appear. Avoid repeated freeze-thaw cycles, which can degrade peptide integrity.

Related reading

Tools and supplies

For laboratory and research reference only. Educational content, not medical, dosing, injection, or therapeutic guidance, and not intended for human or animal use. Any research uses described are investigational and not confirmed or approved benefits. Confirm anything involving health with a licensed professional. References linked above.